Options Brief: Cadence Pharmaceuticals

Shares of Cadence Pharmaceuticals CADX are higher on the session by 1.85%, trading at $9.37. Overall put volume is now running at 25.01x the daily average, with 4% of all puts traded being purchases on the offer. 5,678 contracts have traded on the session so far. Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates for use in the hospital setting.